Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection
Authors:
Open Access
- 6 May 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (5) , e10510
Abstract
Binding of chemokines to glycosaminoglycans (GAGs) is classically described as initiating inflammatory cell migration and creating tissue chemokine gradients that direct local leukocyte chemotaxis into damaged or transplanted tissues. While chemokine-receptor binding has been extensively studied during allograft transplantation, effects of glycosaminoglycan (GAG) interactions with chemokines on transplant longevity are less well known. Here we examine the impact of interrupting chemokine-GAG interactions and chemokine-receptor interactions, both locally and systemically, on vascular disease in allografts. Analysis of GAG or CC chemokine receptor 2 (CCR2) deficiency were coupled with the infusion of viral chemokine modulating proteins (CMPs) in mouse aortic allograft transplants (n = 239 mice). Inflammatory cell invasion and neointimal hyperplasia were significantly reduced in N-deacetylase-N-sulfotransferase-1 (Ndst1f/fTekCre+) heparan sulfate (GAG)-deficient (Ndst1−/−, pCcr2−/−, pCcr2+/+, p≤0.003 and Ccr2−/−, p≤0.027) aortic allografts, but not in Ndst1−/− aortic allografts (p = 0.933). M-T1 and M3 inhibited WT (Ccr2+/+ and Ndst1+/+, p≤0.006) allograft vasculopathy, but did not block vasculopathy in Ccr2−/− (p = 0.61). M-T7 treatment alone, even without immunosuppressive drugs, also significantly prolonged survival of renal allograft transplants (p≤0.001). Interruption of chemokine-GAG interactions, even in the absence of chemokine-receptor blockade, is a highly effective approach to reduction of allograft rejection, reducing vascular inflammation and prolonging allograft survival. Although chemokines direct both local and systemic cell migration, interruption of inherent chemokine responses in the donor tissue unexpectedly had a greater therapeutic impact on allograft vasculopathy.Keywords
This publication has 47 references indexed in Scilit:
- Bone Marrow–Derived Cell-Specific Chemokine (C-C Motif) Receptor-2 Expression is Required for Arteriolar RemodelingArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Jak3 Is Involved in Dendritic Cell Maturation and CCR7-Dependent MigrationPLOS ONE, 2009
- Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden miceJournal of Vascular Surgery, 2009
- Selective human endothelial cell activation by chemokines as a guide to cell homingImmunology, 2009
- Orchestrating the orchestrators: chemokines in control of T cell trafficNature Immunology, 2008
- Inhibition of MCP-1/CCR2 Signaling Does Not Inhibit Intimal Proliferation in a Mouse Aortic Transplant ModelJournal of Vascular Research, 2008
- Connective Tissue Growth Factor is a Biomarker and Mediator of Kidney Allograft FibrosisAmerican Journal of Transplantation, 2006
- Changes in Total Serum Glycosaminoglycan Levels in Patients Undergoing Renal Transplantation: Preliminary DataSurgery Today, 2004
- The BBXB Motif of RANTES Is the Principal Site for Heparin Binding and Controls Receptor SelectivityJournal of Biological Chemistry, 2001
- NEW SYNTHETIC SULFATED OLIGOSACCHARIDES PROLONG SURVIVAL OF CARDIAC XENOGRAFTS BY INHIBITING RELEASE OF HEPARAN SULFATE FROM ENDOTHELIAL CELLSTransplantation, 1996